Garner Asset Management Corp’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,688
Closed -$42K 323
2025
Q4
$42K Buy
+1,688
New +$42.6K 0.02% 242
2024
Q1
Sell
-6,807
Closed -$187K 279
2023
Q4
$187K Sell
6,807
-5,697
-46% -$172K 0.09% 139
2023
Q3
$415K Sell
12,504
-270
-2% -$9.55K 0.24% 108
2023
Q2
$469K Sell
12,774
-2,752
-18% -$107K 0.26% 106
2023
Q1
$633K Buy
15,526
+5
+0% +$216 0.29% 101
2022
Q4
$795K Sell
15,521
-87
-0.6% -$4.17K 0.38% 87
2022
Q3
$683K Sell
15,608
-1,627
-9% -$79.1K 0.35% 88
2022
Q2
$904K Buy
17,235
+717
+4% +$36.5K 0.39% 83
2022
Q1
$855K Hold
16,518
0.34% 90
2021
Q4
$975K Sell
16,518
-500
-3% -$24.8K 0.4% 81
2021
Q3
$732K Buy
17,018
+14
+0.1% +$620 0.33% 93
2021
Q2
$666K Sell
17,004
-65
-0.4% -$2.53K 0.31% 100
2021
Q1
$618K Buy
17,069
+2,730
+19% +$96.9K 0.31% 100
2020
Q4
$528K Buy
14,339
+4,271
+42% +$157K 0.29% 105
2020
Q3
$351K Buy
10,068
+108
+1% +$3.79K 0.23% 120
2020
Q2
$309K Buy
9,960
+1,465
+17% +$49.8K 0.23% 119
2020
Q1
$263K Sell
8,495
-184
-2% -$6.27K 0.24% 112
2019
Q4
$323K Hold
8,679
0.22% 112
2019
Q3
$296K Sell
8,679
-894
-9% -$32.5K 0.22% 112
2019
Q2
$393K Buy
9,573
+317
+3% +$12.6K 0.3% 101
2019
Q1
$373K Buy
9,256
+61
+0.7% +$2.44K 0.3% 99
2018
Q4
$381K Hold
9,195
0.34% 92
2018
Q3
$384K Hold
9,195
0.29% 101
2018
Q2
$317K Buy
9,195
+58
+0.6% +$1.98K 0.25% 110
2018
Q1
$308K Buy
9,137
+450
+5% +$15.5K 0.26% 111
2017
Q4
$299K Buy
8,687
+88
+1% +$3K 0.25% 118
2017
Q3
$291K Sell
8,599
-158
-2% -$5.08K 0.26% 116
2017
Q2
$279K Buy
+8,757
New +$276K 0.26% 117

Other funds holding PFE

Garner Asset Management Corp's PFE Position: Q1 2026 in Review

Garner Asset Management Corp sold out of Pfizer (PFE) in Q1 2026, closing a stake of 1,688 shares — an estimated $42K sold.

Garner Asset Management Corp first reported a position in PFE in Q2 2017 and held it in 28 quarters. The position peaked at $975K in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Garner Asset Management Corp reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Garner Asset Management Corp sold 1,688 Pfizer shares in Q1 2026, an estimated $42K.
  • Garner Asset Management Corp first reported a position in Pfizer in Q2 2017 and held it in 28 quarters.
  • Garner Asset Management Corp's Pfizer position peaked at $975K in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Garner Asset Management Corp's 13F filing for Q1 2026, filed 29 Apr 2026.